Biznesradar bez reklam? Sprawdź BR Plus
Wiadomości INC
1.500+0.060(+4.17%)INC SPÓŁKA AKCYJNA
GPW - Akcje/PDA - Notowania ciągłe
Biznesradar bez reklam? Sprawdź BR Plus
Viavi Solutions Inc. surged 8.9% Wednesday to $41.83 despite mixed signals from Wall Street analysts. The communication equipment maker saw shares climb on ...
The post Viavi Solutions Jumps 8.9% After UBS Maintains Neutral first appeared on Alphastreet.
Lexeo Therapeutics, Inc.
The post Lexeo Therapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
Unicycive Therapeutics, Inc.
The post Unicycive Therapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
Stran & Company, Inc.
The post Stran & Company Releases Q2 2026 Financial Results first appeared on Alphastreet.
Adagene Inc.
The post Adagene Releases 1H 2026 Financial Results first appeared on Alphastreet.
Sutro Biopharma, Inc.
The post Sutro Biopharma Releases Q2 2026 Financial Results first appeared on Alphastreet.
WeRide Inc.
The post WeRide Releases Q2 2026 Financial Results first appeared on Alphastreet.
SUNation Energy Inc. (SUNE) posted Q2 2026 Basic and diluted net loss per share EPS of -$0.52.
The post SUNation Energy Releases Q2 2026 Financial Results first appeared on Alphastreet.
American Integrity Insurance Group, Inc.
The post American Integrity Insurance Group (AII) Q2 2026: Earnings Are In first appeared on Alphastreet.
Cypherpunk Technologies Inc.
The post Cypherpunk Technologies Releases Q2 2026 Financial Results first appeared on Alphastreet.
TScan Therapeutics, Inc.
The post TScan Therapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
Xilio Therapeutics, Inc.
The post Xilio Therapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
Kontoor Brands, Inc.
The post Kontoor Brands Releases Q2 2026 Financial Results first appeared on Alphastreet.
Applied Aerospace & Defense, Inc.
The post Applied Aerospace & Defense Releases Q2 2026 Financial Results first appeared on Alphastreet.
Altimmune, Inc. (ALT) posted a Q2 2026 basic and diluted loss of $0.12 per share, narrower than the -$0.14 expected loss (14.3% narrower).
The post Altimmune Releases Q2 2026 Financial Results first appeared on Alphastreet.
Stabilis Solutions, Inc.
The post Stabilis Solutions Releases Q2 2026 Financial Results first appeared on Alphastreet.
ERock, Inc.
The post ERock Releases Q2 2026 Financial Results first appeared on Alphastreet.
Protalix BioTherapeutics, Inc.
The post Protalix BioTherapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
Aquestive Therapeutics, Inc. (AQST) posted a Q2 2026 diluted loss per share loss of $0.18 per share, wider than the -$0.11 expected loss (63.6% wider).
The post Aquestive Therapeutics Releases Q2 2026 Financial Results first appeared on Alphastreet.
BETA Technologies, Inc.
The post BETA Technologies Releases Q2 2026 Financial Results first appeared on Alphastreet.
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
Informacje
| ISIN: | PLINCLT00015 |
|---|---|
| Data debiutu: | 09.08.2006 |
| Liczba akcji: | 15 043 099 |
| Kapitalizacja: | 22 564 649 |
| Enterprise Value: | 22 177 649 |
| Branża: | Działalność inwestycyjna |
INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom... INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom działającym w różnych sektorach. Poza prywatnymi przedsiębiorstwami, INC świadczy również usługi doradcze jednostkom samorządu terytorialnego oraz angażuje się w projekty sportowe, kulturalne i akademickie.
Biznesradar bez reklam? Sprawdź BR Plus
